Cocrystal Pharma Inc. (COCP)
NASDAQ: COCP
· Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.72
1.11%
After-hours: Aug 15, 2025, 04:31 PM EDT
Cocrystal Pharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -2.3M | -3.27M | -4.94M | -5.34M | -3.96M | -4.46M | -4.17M | -4.17M | -5.19M | -4.5M | -5.7M | -24.43M | -4.21M | -3.69M | -3.94M | -3.82M | -2.74M |
Depreciation & Amortization | 25K | 101K | 30K | 211K | 35K | -1.7M | 108K | 101K | 103K | 100K | 98K | 144K | 46K | 48K | 50K | 47K | 45K |
Stock-Based Compensation | 82K | 85K | 253K | 148K | 157K | 158K | 173K | 179K | 291K | 159K | 216K | 241K | 239K | 222K | 205K | 78K | 219K |
Other Working Capital | n/a | 548.67K | -1.51M | 1.19M | 257K | 52.17K | 234.47K | 169.02K | -1.96M | -275K | -3.8M | 1.93M | 57K | 173K | 61.21M | 1.13M | 32.23M |
Other Non-Cash Items | n/a | -65.67K | -60.66K | -111.98K | 1.22M | -134.33K | -57K | -59K | -56K | -55K | -52K | 19.04M | -61K | -49K | -49K | -49K | -48K |
Deferred Income Tax | n/a | n/a | n/a | n/a | n/a | 2.38M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -22K | -17K | -9K | -1K |
Change in Working Capital | n/a | -14.33K | -467K | 1.46M | -739K | 893.36K | 1.26M | -1.6M | 1.74M | -596K | -3.47M | 1.28M | 74K | 564K | -1.65M | 1.13M | 753K |
Operating Cash Flow | -2.94M | -3.16M | -5.18M | -3.64M | -4.5M | -2.86M | -2.68M | -5.55M | -3.11M | -4.89M | -8.91M | -3.72M | -3.91M | -2.92M | -5.4M | -2.62M | -1.77M |
Capital Expenditures | n/a | n/a | -59.17 | 59.17 | -8K | -57.01K | -1.54K | -14K | -45K | -12K | -62K | n/a | n/a | -8K | -4K | -15K | -25K |
Cash Acquisitions | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Purchase of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Sales Maturities Of Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Investing Acitivies | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Investing Cash Flow | n/a | n/a | -59.17 | 59.17 | -8K | -57.01K | -1.54K | -14K | -45K | -12K | -62K | n/a | n/a | -8K | -4K | -15K | -25K |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -7K | -7K | -7K | -7K | -6K | -9K | -11K | -10K | -9K |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | n/a | n/a | n/a | n/a | n/a | 306.00 | n/a | 4M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Financial Cash Flow | n/a | n/a | n/a | n/a | n/a | -174.37K | 104.47K | 4K | -7 | -7K | -7K | -7K | -6K | -9K | -11K | 36.42M | 2.06M |
Net Cash Flow | -2.94M | -3.16M | -5.12M | -3.7M | -4.51M | -3.38M | -2.68M | -1.56M | -3.16M | -4.91M | -8.98M | -3.73M | -3.92M | -2.94M | -5.42M | 33.78M | 268K |
Free Cash Flow | -2.94M | -3.16M | -5.12M | -3.7M | -4.51M | -2.92M | -2.68M | -5.56M | -3.16M | -4.91M | -8.97M | -3.72M | -3.91M | -2.93M | -5.41M | -2.64M | -1.79M |